Shares in Outlook Therapeutics lost more than half their value after the FDA turned down the company's marketing application for its new formulation of bevacizumab gamma as a treatment for wet ...
I Love LA Recap: Your Favorite Reference, Baby Nothing triggers an existential crisis quite like a daytime party in the Hollywood Hills. overnights Yesterday at 10:32 p.m. The Chair Company Recap: The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback